Tilray Brands Inc (TLRY)
2.58
+0.10
(+4.03%)
USD |
NASDAQ |
Mar 28, 12:16
Tilray Brands Enterprise Value: 2.092B for March 27, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
March 27, 2024 | 2.092B |
March 26, 2024 | 1.964B |
March 25, 2024 | 1.843B |
March 22, 2024 | 1.964B |
March 21, 2024 | 1.692B |
March 20, 2024 | 1.715B |
March 19, 2024 | 1.669B |
March 18, 2024 | 1.669B |
March 15, 2024 | 1.526B |
March 14, 2024 | 1.428B |
March 13, 2024 | 1.481B |
March 12, 2024 | 1.488B |
March 11, 2024 | 1.481B |
March 08, 2024 | 1.503B |
March 07, 2024 | 1.458B |
March 06, 2024 | 1.450B |
March 05, 2024 | 1.466B |
March 04, 2024 | 1.503B |
March 01, 2024 | 1.526B |
February 29, 2024 | 1.526B |
February 28, 2024 | 1.541B |
February 27, 2024 | 1.586B |
February 26, 2024 | 1.533B |
February 23, 2024 | 1.549B |
February 22, 2024 | 1.571B |
Date | Value |
---|---|
February 21, 2024 | 1.564B |
February 20, 2024 | 1.579B |
February 16, 2024 | 1.669B |
February 15, 2024 | 1.617B |
February 14, 2024 | 1.609B |
February 13, 2024 | 1.556B |
February 12, 2024 | 1.647B |
February 09, 2024 | 1.639B |
February 08, 2024 | 1.647B |
February 07, 2024 | 1.647B |
February 06, 2024 | 1.707B |
February 05, 2024 | 1.586B |
February 02, 2024 | 1.639B |
February 01, 2024 | 1.700B |
January 31, 2024 | 1.601B |
January 30, 2024 | 1.654B |
January 29, 2024 | 1.700B |
January 26, 2024 | 1.662B |
January 25, 2024 | 1.722B |
January 24, 2024 | 1.707B |
January 23, 2024 | 1.752B |
January 22, 2024 | 1.752B |
January 19, 2024 | 1.730B |
January 18, 2024 | 1.685B |
January 17, 2024 | 1.775B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
562.09M
Minimum
Mar 18 2020
9.965B
Maximum
Jun 09 2021
2.690B
Average
1.870B
Median
Sep 30 2022
Enterprise Value Benchmarks
Clever Leaves Holdings Inc | 3.311M |
Flora Growth Corp | 13.54M |
Acasti Pharma Inc | 6.844M |
Aurinia Pharmaceuticals Inc | 372.60M |
Edesa Biotech Inc | 9.847M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -49.01M |
Revenue (Quarterly) | 193.77M |
Total Expenses (Quarterly) | 228.46M |
EPS Diluted (Quarterly) | -0.07 |
Gross Profit Margin (Quarterly) | 24.47% |
Profit Margin (Quarterly) | -25.29% |
Earnings Yield | -86.05% |
Normalized Earnings Yield | -22.31 |